4//SEC Filing
Harvey Brian Nicholas 4
Accession 0001209191-22-044902
CIK 0001720580other
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 8:27 PM ET
Size
7.1 KB
Accession
0001209191-22-044902
Insider Transaction Report
Form 4
Adicet Bio, Inc.ACET
Harvey Brian Nicholas
Chief Financial Officer
Transactions
- Award
Common Stock
2022-08-04+16,000→ 70,608 total - Tax Payment
Common Stock
2022-08-04$18.25/sh−4,696$85,702→ 65,912 total
Footnotes (1)
- [F1]The Reporting Person was issued 80,000 Restricted Stock Units ("RSUs") on October 1, 2021, as previously reported on a Form 4 filed by the Reporting Person on October 5, 2021. Each RSU represents a contingent right to receive one share of common stock. A total of 32,000 of the RSUs shall vest in two (2) annual installments of 20% of the shares vesting, with the first tranche vesting on October 1, 2022 and the second tranche vesting on October 1, 2023. A total of 48,000 of the RSUs shall vest upon achievements of specific milestones outlined in the Reporting Person's Restricted Stock Unit Agreement. On August 4, 2022, upon the occurrence of the third performance milestone, 16,000 of the RSUs vested. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance.
Documents
Issuer
Adicet Bio, Inc.
CIK 0001720580
Entity typeother
Related Parties
1- filerCIK 0001519432
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 8:27 PM ET
- Size
- 7.1 KB